POLYAMINE UPTAKE BY HUMAN COLON-CARCINOMA CELL-LINE CACO-2

被引:40
|
作者
DAGOSTINO, L
PIGNATA, S
DANIELE, B
DADAMO, G
FERRARO, C
SILVESTRO, G
TAGLIAFERRI, P
CONTEGIACOMO, A
GENTILE, R
TRITTO, G
BIANCO, AR
MAZZACCA, G
机构
[1] NAPLES UNIV,FAC MED 2A,CATTEDRA ONCOL MED,I-80131 NAPLES,ITALY
[2] NAPLES UNIV,FAC MED 2,DIPARTIMENTO BIOL & PATOL CELLULARE & MOLEC,I-80131 NAPLES,ITALY
关键词
Membrane uptake; Ornithine decarboxylase; Polyamines; Small intestine; α-Difluoromethylornithine;
D O I
10.1159/000200408
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The intracellular concentrations of the polyamines are highly regulated and high polyamine concentrations are associated with rapidly proliferating cells. Hormones, nutrients and growth factors that stimulate the proliferation of the intestinal epithelium, increase the intracellular polyamine concentration mainly by activating ODC expression. Other cell types stimulated to proliferate satisfy their requirement for polyamines by increasing polyamine uptake. In the present study, we investigated polyamine uptake by a human colon carcinoma cell line, CaCo-2. Uptake of putrescine, spermidine and spermine by CaCo-2 cells was saturable and temperature dependent and all polyamines appear to share a common carrier. The carrier of differentiated cells had an apparently higher affinity and lower activity than the carrier of replicating cells. Culture of CaCo-2 cells on porous filters showed that polyamine accumulation occurred mainly through the basolateral membrane in replicating cells, while an increase in the rate of apical uptake was observed after differentiation. A significant increase in polyamine uptake and in ODC expression resulted from fresh medium replacement, a well-known stimulus to proliferation; no change in uptake occurred after ODC inhibition by DFMO. We conclude that CaCo-2 cells are able to increase their polyamine concentration by both enhanced synthesis and increased polyamine uptake. © 1990 S. Karger AG, Basel.
引用
收藏
页码:352 / 359
页数:8
相关论文
共 50 条
  • [1] PHOSPHODIESTERASE IN HUMAN COLON-CARCINOMA CELL-LINE CACO-2 IN CULTURE
    SAVINI, F
    BERARDI, S
    TATONE, D
    SPOTO, G
    [J]. LIFE SCIENCES, 1995, 56 (22) : PL421 - PL425
  • [2] QUANTIFICATION OF PROTEIN TRANSCYTOSIS IN THE HUMAN COLON-CARCINOMA CELL-LINE CACO-2
    HEYMAN, M
    CRAINDENOYELLE, AM
    NATH, SK
    DESJEUX, JF
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 143 (02) : 391 - 395
  • [3] ADHESION OF ENTEROTOXIGENIC ESCHERICHIA-COLI TO THE HUMAN COLON-CARCINOMA CELL-LINE CACO-2 IN CULTURE
    DARFEUILLE-MICHAUD, A
    AUBEL, D
    CHAUVIERE, G
    RICH, C
    BOURGES, M
    SERVIN, A
    JOLY, B
    [J]. INFECTION AND IMMUNITY, 1990, 58 (04) : 893 - 902
  • [4] Sulphation of lithocholic acid in the colon-carcinoma cell line CaCo-2
    Halvorsen, B
    Kase, BF
    Prydz, K
    Garagozlian, S
    Andresen, MS
    Kolset, SO
    [J]. BIOCHEMICAL JOURNAL, 1999, 343 : 533 - 539
  • [5] THE EFFECTS OF 5-FLUOROURACIL AND METHOTREXATE ON THE DEOXYURIDINE SUPPRESSION TEST IN THE HUMAN COLON-CARCINOMA CELL-LINE CACO-2
    CHOI, SW
    SHANE, B
    SELHUB, J
    [J]. FASEB JOURNAL, 1994, 8 (04): : A96 - A96
  • [6] REGULATION OF C-FOS EXPRESSION BY SODIUM-BUTYRATE IN THE HUMAN COLON-CARCINOMA CELL-LINE CACO-2
    SOULEIMANI, A
    ASSELIN, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (01) : 330 - 336
  • [7] CONTROL OF CARCINOEMBRYONIC ANTIGEN GENE FAMILY EXPRESSION IN A DIFFERENTIATING COLON-CARCINOMA CELL-LINE, CACO-2
    HAUCK, W
    STANNERS, CP
    [J]. CANCER RESEARCH, 1991, 51 (13) : 3526 - 3533
  • [8] ENDOCYTOSIS IN HUMAN COLON CANCER CELL-LINE CACO-2
    HEYMAN, M
    CRAINDENOYELLE, AM
    NATH, SK
    DESJEUX, JF
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (05): : 468 - 468
  • [9] REGULATION OF C-MYC EXPRESSION BY SODIUM-BUTYRATE IN THE COLON-CARCINOMA CELL-LINE CACO-2
    SOULEIMANI, A
    ASSELIN, C
    [J]. FEBS LETTERS, 1993, 326 (1-3): : 45 - 50
  • [10] Sulfotransferases in a human colon carcinoma cell line, Caco-2
    Satoh, T
    Masui, M
    Tamura, H
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (07) : 810 - 814